Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3,502 patients

Multiple forms of definitive radiotherapy are acceptable alternatives to more prolonged radiotherapy regimens for men with intermediate-risk prostate cancer (PCa) and can be considered for men with low-risk disease who decline active surveillance.[1] Stereotactic body radiotherapy (SBRT) is an external beam radiotherapy modality in which large radiation doses are delivered over five or fewer fractions. Two forms of brachytherapy -- permanent seed implant low dose rate brachytherapy (LDR-BT) and temporary interstitial implant high dose rate brachytherapy (HDR-BT) -- are also options.

Source: Radiotherapy and Oncology - July 10, 2020 Category: Radiology Authors: Rebecca Levin-Epstein, Ryan R. Cook, J. Karen Wong, Richard G. Stock, D. Jeffrey Demanes, Sean P. Collins, Nima Aghdam, Simeng Suy, Constantine Mantz, Alan J. Katz, Nicholas G. Nickols, Leszek Miszczyk, Aleksandra Napieralska, Agnieszka Namysl-Kaletka, Ni Tags: Original Article Source Type: research